Carbene Footprinting Directs Design of Genetically Encoded Proximity-Reactive Protein Binders-Reference-Cited by-同舟云学术

Carbene Footprinting Directs Design of Genetically Encoded Proximity-Reactive Protein Binders

Published:2024-04-29 Issue:19 Volume:96 Page:7566-7576
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Ye Hui¹^ORCID,Zhu Yinxue²,Kong Ying²,Wen Hongtao¹,Lu Wenjie²,Wang Dexiang¹,Tang Shuo³,Zhan Mengru³,Lu Gaoyuan²^ORCID,Shao Chang¹,Wang Nanxi³^ORCID,Hao Haiping¹²

Affiliation:

1. Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Tongjiaxiang No. 24, Nanjing 210009, Jiangsu, China

2. School of Pharmacy, China Pharmaceutical University, Tongjiaxiang No. 24, Nanjing 210009, Jiangsu, China

3. State Key Laboratory Cultivation Base for TCM Quality and Efficacy, School of Pharmacy, Nanjing University of Chinese Medicine, No. 138 Xianlin Avenue, Nanjing 210023, Jiangsu, China

Funder

National Key Research and Development Program of China

Basic and Applied Basic Research Foundation of Guangdong Province

Natural Science Foundation of Jiangsu Province

Sanming Project of Medicine in Shenzen Municipality

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Overseas Expertise Introduction Project for Discipline Innovation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.4c00424

Reference41 articles.

1. Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

2. Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions

3. State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors

4. Genetically Introducing Biochemically Reactive Amino Acids Dehydroalanine and Dehydrobutyrine in Proteins

5. Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics